Market Update: Stocks are slightly higher, with strong performances from big banks following positive presentations, while cyclicals like industrials and materials lagged. Bond yields are rising, and upcoming PPI and CPI reports may influence rate cut expectations ahead of the Federal Reserve meeting.
Wells Fargo Insights: Wells Fargo's stock rose after positive mid-quarter updates from CFO Mike Santomassimo, highlighting growth opportunities post-lifting of the asset cap, increased share buybacks, and a focus on expanding the credit card business.
Eli Lilly Developments: Eli Lilly's shares increased after a report deemed GLP-1 obesity drugs cost-effective, potentially improving coverage and access. The company also launched an AI platform, Lilly TuneLab, to enhance drug discovery for biotech firms.
Boeing Performance: Boeing reported 57 aircraft deliveries in August, its best performance since 2018, with a focus on increasing production capacity for the 737 MAX. Upcoming earnings reports from Oracle, Synopsys, and Chewy are anticipated.
Wall Street analysts forecast ORCL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ORCL is 309.59 USD with a low forecast of 180.00 USD and a high forecast of 400.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
34 Analyst Rating
Wall Street analysts forecast ORCL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ORCL is 309.59 USD with a low forecast of 180.00 USD and a high forecast of 400.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
25 Buy
9 Hold
0 Sell
Moderate Buy
Current: 178.180
Low
180.00
Averages
309.59
High
400.00
Current: 178.180
Low
180.00
Averages
309.59
High
400.00
Morgan Stanley
Equal Weight
downgrade
$320 -> $213
2026-01-23
New
Reason
Morgan Stanley
Price Target
$320 -> $213
AI Analysis
2026-01-23
New
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Oracle to $213 from $320 and keeps an Equal Weight rating on the shares. GPU-as-a-Service is "a sizable revenue opportunity," but the firm's work suggests the buildout will push Oracle EPS below targets and drive materially higher funding needs, the analyst says. The firm struggles to see a viable path to Oracle's EPS targets, which is a view factored into the current share price and reduced price target, the analyst tells investors. Meanwhile, even after underperformance, the firm thinks key risks, including its own new higher forecasts for funding needs and leverage, are not reflected in spreads from the credit perspective, so it recommends buying CDS and selling benchmark bonds, the analyst added.
Guggenheim
maintain
$400
2026-01-20
New
Reason
Guggenheim
Price Target
$400
2026-01-20
New
maintain
Reason
Guggenheim contends that Oracle will likely maintain its investment grade credit rating, even as capex ramps up earlier than the Street and the bond rating agencies expect, and argues that Oracle remains "the best opportunity in the Software sector." The firm believes "even more strongly" that this is a "decade stock" that will grow EPS at hyper rates, and free cash flow will "eventually waterfall into very significant numbers," but investors will have to wait for that to happen. While "we keep calling this a decade stock (because we believe it is), we expect the numbers to be irrefutable in half that time and be obvious long before that," adds the analyst, who notes that Oracle remains his Best Idea with a $400 price target and Buy rating.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ORCL
Unlock Now
UBS
Buy
downgrade
$325 -> $280
2026-01-05
Reason
UBS
Price Target
$325 -> $280
2026-01-05
downgrade
Buy
Reason
UBS lowered the firm's price target on Oracle to $280 from $325. Oracle's 41% drop from mid-September highs reflects investor concerns about its outlook and OpenAI's impact on related stocks, the analyst tells investors in a research note. Despite this, UBS reaffirms its Buy rating given pending revenue growth, the ramp of Abilene data center capacity, potential reversal of cautious OpenAI sentiment in 1H26, and largely embedded credit/financing risks.
RBC Capital
Rishi Jaluria
Sector Perform
downgrade
$250 -> $195
2026-01-05
Reason
RBC Capital
Rishi Jaluria
Price Target
$250 -> $195
2026-01-05
downgrade
Sector Perform
Reason
RBC Capital analyst Rishi Jaluria lowered the firm's price target on Oracle to $195 from $250 and keeps a Sector Perform rating on the shares. 2026 is likely to be a year when AI tailwinds become more evident for companies well positioned for enterprise AI adoption, while less prepared peers may remain pressured by the "AI is the death of software" narrative, the analyst tells investors in a research note. Enterprise spending appears to be stabilizing and improving in select areas, with GenAI driving innovation even as management teams remain conservative in early 2026 guidance, the firm says.
About ORCL
Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
